756520-68-0

Basic information

• Product Name: 1-(2-chloro-3,6-difluorophenyl)ethan-1-ol
• Synonyms: 1-(2-chloro-3,6-difluorophenyl)ethan-1-ol
• CAS NO: 756520-68-0
• Molecular Weight: 192.593
• Mol File: 756520-68-0.mol

Chemical Properties

• CAS DataBase Reference: 1-(2-chloro-3,6-difluorophenyl)ethan-1-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(2-chloro-3,6-difluorophenyl)ethan-1-ol(756520-68-0)
• EPA Substance Registry System: 1-(2-chloro-3,6-difluorophenyl)ethan-1-ol(756520-68-0)

Safety Data

• Hazardous Substances Data: 756520-68-0(Hazardous Substances Data)

Upstream product

• 261762-39-4 2-chloro-3,6-difluorobenzaldehyde 
• 676-58-4 methylmagnesium chloride 
• 75-16-1 methylmagnesium bromide 

Downstream Products

• 1613148-39-2 3-(1-(2-chloro-3,6-difluorophenyl)ethoxy)-5-(6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-3-yl)pyridin-2-amine 
• 1613148-45-0 3-(1-(2-chloro-3,6-difluorophenyl)ethoxy)-5-(6-trityl-6,7-dihydro-5H-pyrrolo[3,4-b]pyridin-3-yl)pyridin-2-amine 
• 1613148-43-8 N,N-bis(tert-butoxycarbonyl)-3-(1-(2-chloro-3,6-difluorophenyl)ethoxy)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine 
• 1613148-42-7 5-bromo-N,N-bis(tert-butoxycarbonyl)-3-(1-(2-chloro-3,6-difluorophenyl)ethoxy)pyridin-2-amine 
• 756503-70-5 5-bromo-3-(1-(2-chloro-3,6-difluorophenyl)ethoxy)pyridin-2-amine 
• 1613148-41-6 3-(1-(2-chloro-3,6-difluorophenyl)ethoxy)pyridin-2-amine 
• 1613148-40-5 3-(1-(2-chloro-3,6-difluorophenyl)ethoxy)-2-nitropyridine 
• 890934-10-8 1-(2-chloro-3,6-difluorophenyl)ethan-1-one 
• 957198-21-9 2-(1-bromoethyl)-3-chloro-1,4-difluorobenzene 

Relevant articles and documents

SUBSTITUTED CONDENSED THIOPHENES AS MODULATORS OF STING

A compound of formula (I), wherein: R1 is selected from (i) H, (ii) C3-6cycloalkyl, (iii) C3-7heterocyclyl optionally substituted with a group selected from: methyl and ester, and (iv) linear or branched C1-4alkyl optionally substituted with a group selected from: alkoxy, amino, amido, acylamido, acyloxy, alkyl carboxyl ester, alkyl carbamoyl, alkyl carbamoyl ester, phenyl, phosphonate ester, C3-7heterocyclyl optionally substituted with a group selected from methyl and oxo, and a naturally occurring amino acid, optionally N-substituted with a group selected from methyl, acetyl and boc; A1 is CRA or N; A2 is CRB or N; A3 is CRC or N; A4 is CRD or N; where no more than two of A1, A2, A3, and A4 may be N; one or two of RA, RB, RC, and RD, (if present) are selected from H, F, Cl, Br, Me, CF3, cyclopropyl, cyano, OMe, OEt, CH2OH, CH2OMe and CH2NMe2; the remainder of RA, RB, RC, and RD, (if present) are H; Y is O, NH or CH2; RY is selected from: (RYA) and (RYB).

Substituted pyridine compound and its method and use thereof

The invention relates to a novel substitutive pyridine compound, and a pharmaceutically acceptable salt and a pharmaceutical preparation of the substitutive pyridine compound for regulating the activity of protein kinases and regulating signal responses between cells or in the cells. Meanwhile, the invention further relates to a pharmaceutical composition containing the compound provided by the invention, and a method for treating high proliferative diseases of mammals, especially human with the pharmaceutical composition.

AZABICYCLONONENE DERIVATIVES AS RENIN INHIBITORS

The invention relates to novel bicyclononene derivatives, related compounds and use thereof as active ingredients in the preparation of pharmaceutical compositions. The invention also concerns related aspects including processes for the preparation of the

AMINOHETEROARYL COMPOUNDS AS PROTEIN KINASE INHIBITORS

Aminopyridine and aminopyrazine compounds of formula (1), compositions including these compounds, and methods of their use are provided. Preferred compounds of formula 1 have activity as protein kinase inhibitors, including as inhibitors of c-MET.